NO20005683L - Ny formulering inneholdende paroxetin - Google Patents

Ny formulering inneholdende paroxetin

Info

Publication number
NO20005683L
NO20005683L NO20005683A NO20005683A NO20005683L NO 20005683 L NO20005683 L NO 20005683L NO 20005683 A NO20005683 A NO 20005683A NO 20005683 A NO20005683 A NO 20005683A NO 20005683 L NO20005683 L NO 20005683L
Authority
NO
Norway
Prior art keywords
formulation containing
new formulation
containing paroxetine
paroxetine
hemihydrate
Prior art date
Application number
NO20005683A
Other languages
English (en)
Other versions
NO20005683D0 (no
Inventor
David Philip Elder
Graham Stanley Leonard
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of NO20005683D0 publication Critical patent/NO20005683D0/no
Publication of NO20005683L publication Critical patent/NO20005683L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Paroxetinhydroklorid, i en annen form enn hemihydratet, som er benyttet i tabletter under betingelser som er slik at det ikke er noen påviselig omdannelse til hemihydrat under tabletteringsprosessen.
NO20005683A 1998-05-13 2000-11-10 Ny formulering inneholdende paroxetin NO20005683L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9810181.9A GB9810181D0 (en) 1998-05-13 1998-05-13 Novel formulations
PCT/GB1999/001520 WO1999058113A2 (en) 1998-05-13 1999-05-13 Novel formulation containing paroxetine

Publications (2)

Publication Number Publication Date
NO20005683D0 NO20005683D0 (no) 2000-11-10
NO20005683L true NO20005683L (no) 2000-12-05

Family

ID=10831927

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20005683A NO20005683L (no) 1998-05-13 2000-11-10 Ny formulering inneholdende paroxetin

Country Status (20)

Country Link
EP (1) EP1077682A2 (no)
JP (1) JP2002514591A (no)
KR (1) KR20010043574A (no)
CN (1) CN1308521A (no)
AP (1) AP2000002019A0 (no)
AU (1) AU3940999A (no)
BG (1) BG105010A (no)
BR (1) BR9910401A (no)
CA (1) CA2331871A1 (no)
EA (1) EA200001174A1 (no)
GB (1) GB9810181D0 (no)
HU (1) HUP0102064A2 (no)
ID (1) ID28019A (no)
IL (1) IL139594A0 (no)
NO (1) NO20005683L (no)
PL (1) PL344573A1 (no)
SK (1) SK17142000A3 (no)
TR (1) TR200003350T2 (no)
WO (1) WO1999058113A2 (no)
ZA (1) ZA200006562B (no)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0003232D0 (en) * 2000-02-11 2000-04-05 Smithkline Beecham Plc Novel composition
CA2359812C (en) 2000-11-20 2004-02-10 The Procter & Gamble Company Pharmaceutical dosage form with multiple coatings for reduced impact of coating fractures
WO2003044012A1 (en) * 2001-10-22 2003-05-30 Synthon B.V. N-formyl derivatives of paroxetine
GB2636182A (en) * 2023-12-04 2025-06-11 Novumgen Ltd An orally disintegrating tablet of paroxetine and its process of preparation

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9325644D0 (en) * 1993-12-15 1994-02-16 Smithkline Beecham Plc Novel formulation
US5672612A (en) * 1996-09-09 1997-09-30 Pentech Pharmaceuticals, Inc. Amorphous paroxetine composition
JP2001508460A (ja) * 1997-01-15 2001-06-26 スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー パロキセチン組成物
BR9813808A (pt) * 1997-12-19 2002-05-28 Smithkline Beecham Corp Processo para produção de comprimidos para dispersão na mordida

Also Published As

Publication number Publication date
TR200003350T2 (tr) 2001-03-21
PL344573A1 (en) 2001-11-05
EP1077682A2 (en) 2001-02-28
NO20005683D0 (no) 2000-11-10
GB9810181D0 (en) 1998-07-08
EA200001174A1 (ru) 2001-06-25
AU3940999A (en) 1999-11-29
BG105010A (en) 2001-07-31
JP2002514591A (ja) 2002-05-21
CA2331871A1 (en) 1999-11-18
KR20010043574A (ko) 2001-05-25
ZA200006562B (en) 2002-02-13
AP2000002019A0 (en) 2000-12-31
IL139594A0 (en) 2002-02-10
HUP0102064A2 (hu) 2002-05-29
ID28019A (id) 2001-05-03
CN1308521A (zh) 2001-08-15
WO1999058113A3 (en) 2000-02-17
WO1999058113A2 (en) 1999-11-18
BR9910401A (pt) 2001-01-09
SK17142000A3 (sk) 2001-06-11

Similar Documents

Publication Publication Date Title
FI962445A7 (fi) Paroksetiinitabletteja ja menetelmä niiden valmistamiseksi
SE9600071D0 (sv) New oral formulation of two active ingredients I
DE69626117D1 (de) Orale pharmazeutische zusammensetzungen mit verzögerter freisetzung von reversiblen protonpumpen-inhibitoren
DE60019334D1 (de) Antivirale arznei
NO20060416L (no) Ny anvendelse I
NO20011721D0 (no) N-aralkylaminotetraliner som ligander for neuropeptid Y Y5 reseptor
ATE223236T1 (de) Thyroxine/zyklodextrinkomplexe und ihre pharmazeutische formulierung
ES2137549T3 (es) Derivados antifungicos de sordaridina.
ATE311227T1 (de) Schnell-wirkende, gefrier-trocknete, orale, pharmazeutische formulierung für die behandlung von migräne
NO20060786L (no) Farmasoytiske preparater med oppsvulmbart belegg
ATE291908T1 (de) Ibuprofen-wirkstoffzubereitung
DK1112060T3 (da) Doseringsform anvendende flydende formulering
DK1105105T3 (da) Oral administrationsform til pyridin-2-ylmethylsulfinyl-1H-benzimidazoler
NO20060208L (no) Farmasoytisk preparat
YU45395A (sh) Novo hemijsko jedinjenje, njegovo pripremanje i njegova primena kao leka
AR042652A1 (es) Bromhidrato de escitalopram y un metodo para su preparacion
NO20005681L (no) Nye formuleringer som inneholder paroxetin
HRP20050342B1 (hr) Farmaceutska formulacija olanzapina
NO920234L (no) Helleformulering for paafoering av antihelmintika
NO971851L (no) Barnesikker forpakning for virkestoffinneholdende plaster
DE50010253D1 (de) Substituierte 1- und 2-naphthol-mannichbasen
NO20012673D0 (no) Nytt farmasöytisk preparat og fremgangsmåte for dets fremstilling
FI853768L (fi) Synergistisk sammansaettning som foerhindrar befruktning.
IS4942A (is) Ný lyfjablanda til inngjafar um slímu í munnholi,sérstaklega um nef
AP2000002019A0 (en) Novel formulation containing paroxetine.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application